1. Home
  2. NTHI vs INAC Comparison

NTHI vs INAC Comparison

Compare NTHI & INAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • INAC
  • Stock Information
  • Founded
  • NTHI 2008
  • INAC 2024
  • Country
  • NTHI United States
  • INAC United States
  • Employees
  • NTHI N/A
  • INAC N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • INAC
  • Sector
  • NTHI Health Care
  • INAC
  • Exchange
  • NTHI Nasdaq
  • INAC Nasdaq
  • Market Cap
  • NTHI 155.4M
  • INAC 143.2M
  • IPO Year
  • NTHI N/A
  • INAC 2025
  • Fundamental
  • Price
  • NTHI $9.88
  • INAC $9.94
  • Analyst Decision
  • NTHI
  • INAC
  • Analyst Count
  • NTHI 0
  • INAC 0
  • Target Price
  • NTHI N/A
  • INAC N/A
  • AVG Volume (30 Days)
  • NTHI 72.4K
  • INAC 13.1K
  • Earning Date
  • NTHI 08-19-2025
  • INAC 01-01-0001
  • Dividend Yield
  • NTHI N/A
  • INAC N/A
  • EPS Growth
  • NTHI N/A
  • INAC N/A
  • EPS
  • NTHI N/A
  • INAC N/A
  • Revenue
  • NTHI $59,990.00
  • INAC N/A
  • Revenue This Year
  • NTHI N/A
  • INAC N/A
  • Revenue Next Year
  • NTHI N/A
  • INAC N/A
  • P/E Ratio
  • NTHI N/A
  • INAC N/A
  • Revenue Growth
  • NTHI N/A
  • INAC N/A
  • 52 Week Low
  • NTHI $3.20
  • INAC $10.01
  • 52 Week High
  • NTHI $25.00
  • INAC $10.40
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • INAC N/A
  • Support Level
  • NTHI N/A
  • INAC N/A
  • Resistance Level
  • NTHI N/A
  • INAC N/A
  • Average True Range (ATR)
  • NTHI 0.00
  • INAC 0.00
  • MACD
  • NTHI 0.00
  • INAC 0.00
  • Stochastic Oscillator
  • NTHI 0.00
  • INAC 0.00

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About INAC Indigo Acquisition Corp. Ordinary Shares

Indigo Acquisition Corp is a blank check company.

Share on Social Networks: